Search

Search Constraints

You searched for: Author/Creator Kjøller, Erik

Search Results

1. 10‐Year Associations Between Tumor Necrosis Factor Receptors 1 and 2 and Cardiovascular Events in Patients With Stable Coronary Heart Disease: A CLARICOR (Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease) Trial Substudy. Issue 9 (12 September 0207)

3. Cathepsin B and S as markers for cardiovascular risk and all-cause mortality in patients with stable coronary heart disease during 10 years: a CLARICOR trial sub-study. (November 2018)

4. Circulating endostatin as a risk factor for cardiovascular events in patients with stable coronary heart disease: A CLARICOR trial sub-study. (May 2019)

5. Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10 years in the CLARICOR randomised, blinded clinical trial. (1st March 2015)

6. Early Discharge from the Emergency Department Based on Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels: A TRIAGE III Substudy. (19th May 2019)

7. Introduction of a prognostic biomarker to strengthen risk stratification of acutely admitted patients: rationale and design of the TRIAGE III cluster randomized interventional trial. Issue 1 (December 2016)

8. Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: The CLARICOR trial. (November 2014)

9. Prevalence and significance of troponin elevations in patients without acute coronary disease. (1st November 2016)

10. Prevalence and significance of troponin elevations in patients without acute coronary disease. (1st November 2016)